Methadone

This classification denotes an opiate with the molecular formula C21H27NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UC6VBE7V1Z, chemically known as 6-dimethylamino-4,4-diphenyl-heptan-3-one but generally known as methadone, which bears US NIH Compound Identifier 4095. European Medicines Agency schedules Methadone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08833MIG. The term METHADONE is an International Non-Proprietary Name. World Health Organization schedules methadone in its Anatomical Therapeutic Chemical (ATC) Classification. METHADONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule methadone under HS 29223100 and SITC 51463. As of Q4 2014, METHADONE remains the US FDA Preferred Term for this commodity. Methadone bears US NLM identifiers UMLS ID C0025605 and NCI Concept Code C62044. SMILES: O=C(C(CC(N(C)C)C)(C1CCCCC1)C1CCCCC1)CC.